Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Insulin resistance linked to obesity may increase COVID-19 severity.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.